A recent decision by a California federal judge has advanced the patent infringement lawsuit lodged by Medtronic against Axonics. The case, revolving around an electrical stimulation system, is now slated for trial in September 2024.
The legal proceedings have faced significant delays, with the court previously enacting a stay order. This postponement has now been lifted, allowing for the lawsuit to proceed further.
Medtronic, a well-established name in the medical technology industry, filed this lawsuit alleging that Axonics infringed on its patents for an electrical stimulation system, these systems are often used in therapies that require neuromodulation.
Axonics, a competitor in the same field, will now prepare to mount a defense as the court date approaches. The eventual outcome of the trial could carry immense significance for both parties given the high stakes nature of the medical patent world.
More details are available about this anticipated trial and preceding legal skirmishes.